Hypofractionated radiotherapy does not increase acute toxicity in large-breasted women: Results from a prospectively collected series

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 37, Issue 4, 2014, Pages 322-326

  Corbin, Kimberly S ^a   Dorn, Paige L ^a   Jain, Supriya K ^a   Al Hallaq, Hania A ^a   Hasan, Yasmin ^a   Chmura, Steven J ^a  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

Breast; Hypofractionation; Obese; Radiation

Indexed keywords

AGED; AGED, 80 AND OVER; BODY MASS INDEX; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; DOSE FRACTIONATION; FEMALE; HUMANS; MIDDLE AGED; OBESITY; PROSPECTIVE STUDIES; RADIATION INJURIES; RADIOTHERAPY; SKIN;

EID: 84905122429     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/COC.0b013e31827b45b7     Document Type: Article

References (22)

1. Flegal KM, Carroll MD, Ogden CL, et al. Prevalence and trends in obesity among US adults, 1999-2008. JAMA. 2010; 303: 235-241.
2. Stewart ST, Cutler DM, Rosen AB. Forecasting the effects of obesity and smoking on U.S. life expectancy. N Engl J Med. 2009; 361: 2252-2260.
3. Janiszewski PM, Saunders TJ, Ross R. Breast volume is an independent predictor of visceral and ectopic fat in premenopausal women. Obesity (Silver Spring). 2010; 18: 1183-1187.
4. Schapira DV, Clark RA, Wolff PA, et al. Visceral obesity and breast cancer risk. Cancer. 1994; 74: 632-639.
5. van den Brandt PA, Spiegelman D, Yaun SS, et al. Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. Am J Epidemiol. 2000; 152: 514-527.
6. Whelan TJ, Pignol JP, Levine MN, et al. Long-term results of hypofractionated radiation therapy for breast cancer. N Engl J Med. 2010; 362: 513-520.
7. Group ST, Bentzen SM, Agrawal RK, et al. The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet Oncol. 2008; 9: 331-341.
8. Group ST, Bentzen SM, Agrawal RK, et al. The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet. 2008; 371: 1098-1107.
9. Yarnold J, Ashton A, Bliss J, et al. Fractionation sensitivity and dose response of late adverse effects in the breast after radiotherapy for early breast cancer: long-term results of a randomised trial. Radiother Oncol. 2005; 75: 9-17.
10. Dwyer P, Hickey B, Burmeister E, et al. Hypofractionated wholebreast radiotherapy: impact on departmental waiting times and cost. J Med Imaging Radiat Oncol. 2010; 54: 229-234.
11. Donovan E, Bleakley N, Denholm E, et al. Randomised trial of standard 2D radiotherapy (RT) versus intensity modulated radiotherapy (IMRT) in patients prescribed breast radiotherapy. Radiother Oncol. 2007; 82: 254-264.
12. Pignol JP, Olivotto I, Rakovitch E, et al. A multicenter randomized trial of breast intensity-modulated radiation therapy to reduce acute radiation dermatitis. J Clin Oncol. 2008; 26: 2085-2092.
13. Kestin LL, Sharpe MB, Frazier RC, et al. Intensity modulation to improve dose uniformity with tangential breast radiotherapy: initial clinical experience. Int J Radiat Oncol Biol Phys. 2000; 48: 1559-1568.
14. Deantonio L, Gambaro G, Beldi D, et al. Hypofractionated radiotherapy after conservative surgery for breast cancer: analysis of acute and late toxicity. Radiat Oncol. 2010; 5: 112.
15. Osako T, Oguchi M, Kumada M, et al. Acute radiation dermatitis and pneumonitis in Japanese breast cancer patients with whole breast hypofractionated radiotherapy compared to conventional radiotherapy. Jpn J Clin Oncol. 2008; 38: 334-338.
16. Back M, Guerrieri M, Wratten C, et al. Impact of radiation therapy on acute toxicity in breast conservation therapy for early breast cancer. Clin Oncol (R Coll Radiol). 2004; 16: 12-16.
17. White J, Joiner MC. Toxicity from radiation in breast cancer radiation toxicity: a practical guide. In: Small W, Woloschak GE, eds. Springer USA; 2006: 65-109.
18. Vrieling C, Collette L, Fourquet A, et al. The influence of the boost in breast-conserving therapy on cosmetic outcome in the EORTC "boost versus no boost" trial. EORTC Radiotherapy and Breast Cancer Cooperative Groups. European Organization for Research and Treatment of Cancer. Int J Radiat Oncol Biol Phys. 1999; 45: 677-685.
19. Collette S, Collette L, Budiharto T, et al. Predictors of the risk of fibrosis at 10 years after breast conserving therapy for early breast cancer: a study based on the EORTC Trial 22881-10882 "boost versus no boost". Eur J Cancer. 2008; 44: 2587-2599.
20. Fernando IN, Ford HT, Powels TJ, et al. Factors affecting acute skin toxicity in patients having breast irradiation after conservative surgery: a prospective study of treatment practice at the Royal Marsden Hospital. Clin Oncol (R Coll Radiol). 1996; 8: 226-233.
21. Moody AM, Mayles WP, Bliss JM, et al. The influence of breast size on late radiation effects and association with radiotherapy dose inhomogeneity. Radiother Oncol. 1994; 33: 106-112.
22. Osa EO, Ciervide R, Lymberis S, et al. Three-year outcomes of 490 patients treated with accelerated intensity modulated radiotherapy with a concurrent boost. Int J Radiat Oncol Biol Phys. 2011; 81(suppl 2): S10.